Compare Clinical Trial for Cystic Fibrosis Trials


Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis

Condition: Cystic Fibrosis (CF)Intervention: Device: EasyOne Pro and EcomedicsSponsors: University Hospital St Luc, Brussels; University Hospital St Luc, Brussels; Katholieke Universiteit LeuvenRecruiting – verified Se…

Continue reading about Clinical Trial Long Term Significance (Survival) of LCI in Patients With Cystic Fibrosis

Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

Condition: BronchiectasisInterventions: Drug: BAY85-8501; Drug: PlaceboSponsors: Bayer; BayerRecruiting – verified September 2013

Continue reading about Clinical Trial Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis

Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients

Condition: Cystic FibrosisIntervention: Drug: ivacaftorSponsors: University of California, San Francisco; University of California, San FranciscoNot yet recruiting – verified September 2013

Continue reading about Clinical Trial Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Condition: Cystic FibrosisInterventions: Drug: N6022; Drug: Normal salineSponsors: N30 Pharmaceuticals, Inc.; N30 Pharmaceuticals, Inc.Recruiting – verified September 2013

Continue reading about Clinical Trial Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Conditions: Pancreatic Insufficiency; Cystic Fibrosis; Digestive System Diseases; Lung Diseases; Respiratory Tract DiseasesInterventions: Drug: Burlulipase; Drug: Placebo (Caramel in sterile water)Sponsors: Nordm…

Continue reading about Clinical Trial Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

Condition: Cystic FibrosisIntervention: Drug: IvacaftorSponsors: Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals Incorporated; Cystic Fibrosis FoundationRecruiting – verified September 2013

Continue reading about Clinical Trial Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation

A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)

Condition: Fungal InfectionIntervention: Drug: PosaconazoleSponsors: Merck; MerckNot yet recruiting – verified August 2012

Continue reading about Clinical Trial A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105)

A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis

Condition: Cystic FibrosisInterventions: Drug: Intermittent, short infusion Ceftazidime; Drug: Continuous infusion Ceftazidime; Drug: Intermittent, short infusion Meropenem; Drug: Continuous infusion Meropenem; Drug: …

Continue reading about Clinical Trial A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis

Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis

Condition: Cystic FibrosisIntervention: Sponsors: Yale University; Yale UniversityRecruiting – verified August 2012

Continue reading about Clinical Trial Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis

Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)

Condition: Fibrosing Colonopathy in Patients With Cystic FibrosisInterventions: Biological: CREON; Biological: ZENPEP; Biological: ULTRESA; Biological: PANCREAZE; Biological: other non-sponsor pancreatic enzyme replacement thera…

Continue reading about Clinical Trial Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Any Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)